Correlation Between International CSRC and Medigen Biotechnology

Can any of the company-specific risk be diversified away by investing in both International CSRC and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining International CSRC and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between International CSRC Investment and Medigen Biotechnology, you can compare the effects of market volatilities on International CSRC and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in International CSRC with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of International CSRC and Medigen Biotechnology.

Diversification Opportunities for International CSRC and Medigen Biotechnology

-0.23

Correlation Coefficient

International CSRC  Medigen Biotechnology

Very good diversification

The 3 months correlation between International and Medigen is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding International CSRC Investment and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and International CSRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on International CSRC Investment are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of International CSRC i.e., International CSRC and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between International CSRC and Medigen Biotechnology

Assuming the 90 days trading horizon International CSRC Investment is expected to under-perform the Medigen Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, International CSRC Investment is 1.37 times less risky than Medigen Biotechnology. The stock trades about -0.1 of its potential returns per unit of risk. The Medigen Biotechnology is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  3,180  in Medigen Biotechnology on December 25, 2024 and sell it today you would earn a total of  250.00  from holding Medigen Biotechnology or generate 7.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

International CSRC Investment  vs.  Medigen Biotechnology

International CSRC

Risk-Adjusted Performance

Very Weak

Over the last 90 days International CSRC Investment has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Medigen Biotechnology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medigen Biotechnology may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with International CSRC and Medigen Biotechnology

The main advantage of trading using opposite International CSRC and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if International CSRC position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.

The idea behind International CSRC Investment and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.